We can't find the internet
Attempting to reconnect
29722.1 IP-LS
29722.1 IP-LS
Résumé
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Textes supplémentaires
Abstract
This project aims to validate and provide necessary data on the molecular target(-s) of our novel anti-Wnt signaling scaffold demonstrating excellent anti-cancer properties and safety profile. These data are essential for their acceptance and further structure-driven development in pharma companies.
Participants
Vladimir Katanaev
Kontaktperson
vladimir.katanaev@unige.ch
Université de Genève Vladimir Katanaev Rue Michel Servet 1 1211 Genève GE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-09-30
- Date de fin
- 2021-01-31
- Coûts totaux approuvés
- CHF 265885.49
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%